Cargando…

Perspectives and challenges to discovering hemoglobin-inducing agents in Sickle Cell Disease

Detalles Bibliográficos
Autores principales:	Pavan, Aline Renata, Lopes, Juliana Romano, Lima Imperador, Carlos Henrique, Man Chin, Chung, dos Santos, Jean Leandro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9492863/ https://www.ncbi.nlm.nih.gov/pubmed/36160143 http://dx.doi.org/10.3389/fmed.2022.1002063

Ejemplares similares

Vascular Effects of the Fetal Hemoglobin Inducer Agent 3-(1,3-Dioxoisoindolin-2-yl) Benzyl Nitrate
por: Terroni, Barbara, et al.
Publicado: (2022)

Resveratrol and Curcumin for Chagas Disease Treatment—A Systematic Review
por: Imperador, Carlos Henrique Lima, et al.
Publicado: (2022)

Mutagenicity of New Lead Compounds to Treat Sickle Cell Disease Symptoms in a Salmonella/Microsome Assay
por: dos Santos, Jean Leandro, et al.
Publicado: (2010)

Assessment of the In Vivo Genotoxicity of New Lead Compounds to Treat Sickle Cell Disease
por: dos Santos, Jean Leandro, et al.
Publicado: (2011)

Design and Synthesis of Hybrid Compounds as Epigenetic Modifiers
por: Lopes, Juliana Romano, et al.
Publicado: (2021)

THE STATE OF HEMOGLOBIN IN SICKLED ERYTHROCYTES
por: Stetson, Chandler A.
Publicado: (1966)

Synthesis and Preliminary Evaluation of N-Oxide Derivatives for the Prevention of Atherothrombotic Events
por: Rosseto, Leandro Augusto, et al.
Publicado: (2015)

Epigenetic Regulatory Mechanisms Induced by Resveratrol
por: Fernandes, Guilherme Felipe Santos, et al.
Publicado: (2017)

Gum Arabic as fetal hemoglobin inducing agent in sickle cell anemia; in vivo study
por: Kaddam, Lamis, et al.
Publicado: (2015)

Sickle Cell Disease and Fetal Hemoglobin
por: Rivera, Alicia
Publicado: (2018)

Sickle Cell Disease: quality of life in patients with hemoglobin SS and SC disorders
por: Pereira, Sônia Aparecida dos Santos, et al.
Publicado: (2013)

Unraveling the Anticancer Effect of Curcumin and Resveratrol
por: Pavan, Aline Renata, et al.
Publicado: (2016)

GELS OF NORMAL AND SICKLED HEMOGLOBIN : COMPARATIVE STUDY
por: White, James G., et al.
Publicado: (1970)

Fetal hemoglobin and hemolysis markers in sickle cell anemia()
por: Colella, Marina Pereira, et al.
Publicado: (2015)

Rapid and inefficient kinetics of sickle hemoglobin fiber growth
por: Castle, Brian T., et al.
Publicado: (2019)

Hemoglobin level and macular thinning in sickle cell disease
por: Hussnain, S Amal, et al.
Publicado: (2019)

Bone marrow necrosis and fat embolism syndrome: a dreadful complication of hemoglobin sickle cell disease
por: Targueta, Eduardo Pelegrineti, et al.
Publicado: (2017)

THE PHYSICAL STATE OF HEMOGLOBIN IN SICKLE-CELL ANEMIA ERYTHROCYTES IN VIVO
por: Döbler, Johanna, et al.
Publicado: (1968)

Sickle Retinopathy in a Person with Hemoglobin S/New York Disease
por: Calder, Donovan, et al.
Publicado: (2012)

The Sickle Effect: The Silent Titan Affecting Glycated Hemoglobin Reliability
por: Gordon, Domonick K, et al.
Publicado: (2020)

Fetal hemoglobin rescues ineffective erythropoiesis in sickle cell disease
por: El Hoss, Sara, et al.
Publicado: (2020)

Hemoglobin and End-Organ Damage in Individuals with Sickle Cell Disease
por: Ershler, William B., et al.
Publicado: (2023)

Hierarchical Virtual Screening Based on Rocaglamide Derivatives to Discover New Potential Anti-Skin Cancer Agents
por: dos Santos, Igor V.F., et al.
Publicado: (2022)

A Triazole Disulfide Compound Increases the Affinity of Hemoglobin for Oxygen and Reduces the Sickling of Human Sickle Cells
por: Nakagawa, Akito, et al.
Publicado: (2018)

Fluorescence Lifetime Measurement of Prefibrillar Sickle Hemoglobin Oligomers as a Platform for Drug Discovery in Sickle Cell Disease
por: Vunnam, Nagamani, et al.
Publicado: (2022)

Genetic reversal of the globin switch concurrently modulates both fetal and sickle hemoglobin and reduces red cell sickling
por: De Souza, Daniel C., et al.
Publicado: (2023)

Sociodemographic aspects and quality of life of patients with sickle cell anemia
por: dos Santos, Juliana Pereira, et al.
Publicado: (2013)

An “acquired” hemoglobin J variant in a sickle cell disease patient
por: Swedan, Nawwar, et al.
Publicado: (2008)

The effect of hemoglobin carbamylation on the survival of human sickle cell erythrocytes in rats.
por: Castro, O., et al.
Publicado: (1974)

Fetal hemoglobin reactivation and cell engineering in the treatment of sickle cell anemia
por: Eridani, Sandro, et al.
Publicado: (2011)

Fetal hemoglobin level and nutritional status in patients with sickle cell disease
por: Badawy, Sherif M.
Publicado: (2016)

Human hemoglobin G-Makassar variant masquerading as sickle cell anemia
por: Mohamad, Ahmad Sabry, et al.
Publicado: (2018)

Fetal Hemoglobin in Sickle Hemoglobinopathies: High HbF Genotypes and Phenotypes
por: Steinberg, Martin H.
Publicado: (2020)

The curious case of hemoglobin DC disease masquerading as sickle cell anemia
por: Hirani, Samina, et al.
Publicado: (2020)

Unrecognized hemoglobin SC sickle cell disease complicated by sepsis and cholestasis
por: McFarland, Thomas, et al.
Publicado: (2022)

Non-S Sickling Hemoglobin Variants: Historical, Genetic, Diagnostic, and Clinical Perspectives
por: Ahmed, Sagir G., et al.
Publicado: (2021)

Voxelotor: A Hemoglobin S Polymerization Inhibitor for the Treatment of Sickle Cell Disease
por: Yenamandra, Avani, et al.
Publicado: (2020)

Special Issue “Drug Candidates for the Treatment of Infectious Diseases”
por: Man Chin, Chung, et al.
Publicado: (2023)

Pattern of hemolysis parameters and association with fetal hemoglobin in sickle cell anemia patients in steady state
por: Moreira, Juliane Almeida, et al.
Publicado: (2015)

Role of Extracellular Hemoglobin in Thrombosis and Vascular Occlusion in Patients with Sickle Cell Anemia
por: Zhou, Zhou, et al.
Publicado: (2011)

Cannot write session to /tmp/vufind_sessions/sess_0cutp07dhh53qoj6gvstul4tf0